Indian Journal of Urology Users online:452  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


A randomized trial comparing low dose (40 or 80 mg) with standard dose (120 mg) of bacillus Calmette-Guerin for superficial bladder cancer

Vijjan Vivek, Mandhani Anil, Kapoor Rakesh, Dubey Deepak, Srivastava Aneesh, Ansari M S, Singh Pratipal, Kumar Anant

Year : 2006| Volume: 22| Issue : 4 | Page no: 317-321

   This article has been cited by
1 Low-dose versus standard-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials
Se Young Choi, Moon Soo Ha, Jung Hoon Kim, Byung Hoon Chi, Jin Wook Kim, In Ho Chang, Tae-Hyoung Kim, Soon Chul Myung
Investigative and Clinical Urology. 2022; 63
[Pubmed]  [Google Scholar] [DOI]
2 Intravesical Bacillus Calmette-Guerin (BCG) Therapy for Non-muscle Invasive Bladder Cancers: Long-term Results of a Modified Schedule
Kanuj Malik, Anand Raja, Lalgudi Subramaniam Ravishankar, Kathiresan Narayanaswamy, Venkatraman Radhakrishnan, Tenali Gnana Sagar
Indian Journal of Surgical Oncology. 2021;
[Pubmed]  [Google Scholar] [DOI]
3 Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer—analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow)
Yuvaraja B. Thyavihally, Preetham Dev, Santosh Waigankar, Abhinav Pednekar, Nevitha Athikari, Abhijit Raut, Archan Khandekar, Naresh Badlani, Ashishkumar Asari
Asian Journal of Urology. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 XRCC1 codon 399 mutant allele: A risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
Mittal, R.D., Singh, R., Manchanda, P.K., Ahirwar, D., Gangwar, R., Kesarwani, P., Mandhani, A.
Cancer Biology and Therapy. 2008; 7(5): 647-652
[Pubmed]  [Google Scholar]
5 Bacillus Calmette-Guerin in the management of superficial bladder cancer
Kapoor, R., Vijjan, V., Singh, P.
Indian Journal of Urology. 2008; 24(1): 72-76
[Pubmed]  [Google Scholar]
6 The Safety and Efficacy of Different Doses of Bacillus Calmette Guérin in Superficial Bladder Transitional Cell Carcinoma
Agrawal, M.S. and Agrawal, M. and Bansal, S. and Agarwal, M. and Lavania, P. and Goyal, J.
Urology. 2007; 70(6): 1075-1078
[Pubmed]  [Google Scholar]
7 The Safety and Efficacy of Different Doses of Bacillus Calmette Guérin in Superficial Bladder Transitional Cell Carcinoma
Madhu S. Agrawal,Moneet Agrawal,Sumit Bansal,Mayank Agarwal,Prashant Lavania,Jitendra Goyal
Urology. 2007; 70(6): 1075
[Pubmed]  [Google Scholar] [DOI]


Read this article